KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $96.4 million.

  • Opko Health's Receivables - Net fell 1126.33% to $96.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.4 million, marking a year-over-year decrease of 1126.33%. This contributed to the annual value of $119.3 million for FY2024, which is 486.13% down from last year.
  • Opko Health's Receivables - Net amounted to $96.4 million in Q3 2025, which was down 1126.33% from $101.0 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Receivables - Net ranged from a high of $320.5 million in Q1 2021 and a low of $96.4 million during Q3 2025
  • In the last 5 years, Opko Health's Receivables - Net had a median value of $123.6 million in 2023 and averaged $161.0 million.
  • As far as peak fluctuations go, Opko Health's Receivables - Net soared by 13875.34% in 2021, and later tumbled by 5216.22% in 2022.
  • Opko Health's Receivables - Net (Quarter) stood at $261.5 million in 2021, then tumbled by 49.72% to $131.5 million in 2022, then dropped by 4.64% to $125.4 million in 2023, then fell by 4.86% to $119.3 million in 2024, then decreased by 19.22% to $96.4 million in 2025.
  • Its last three reported values are $96.4 million in Q3 2025, $101.0 million for Q2 2025, and $97.7 million during Q1 2025.